TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32081030

Group type: EXPERIMENTAL
Intervention: sFlt‐1/PlGF ratio ≥38
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: sFlt‐1 and PlGF assays
Number of subjects: 295
Study: 34637519

Group type: EXPERIMENTAL
Intervention: RSV stabilized prefusion F subunit vaccine (RSVpreF) with Tdap
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tdap alone
Number of subjects: 0
Study: 32521097

Group type: EXPERIMENTAL
Intervention: Immediate narrative reconstruction intervention
Number of subjects: 30

Group type: COMPARATOR
Intervention: Delayed narrative reconstruction intervention
Number of subjects: 30
Study: 35849445

Group type: EXPERIMENTAL
Intervention: Combined inspiratory and expiratory muscle training (In/Ex-SC)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo training
Number of subjects: 51
Study: 34370971

Group type: EXPERIMENTAL
Intervention: ChAd/BNT
Number of subjects: 830

Group type: EXPERIMENTAL
Intervention: BNT/ChAd
Number of subjects: 830

Group type: COMPARATOR
Intervention: ChAd/ChAd
Number of subjects: 830

Group type: COMPARATOR
Intervention: BNT/BNT
Number of subjects: 830
Study: 32342642

Group type: EXPERIMENTAL
Intervention: Fish oil (FO) supplementation (5 g/day containing 2 g/day eicosapentaenoic acid and 1 g/day docosahexaenoic acid)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Olive oil (OO) supplementation (5 g/day)
Number of subjects: 24
Study: 33091706

Group type: EXPERIMENTAL
Intervention: Methylene blue (MB) 2 mg/kg intravenous infusion
Number of subjects: 248

Group type: COMPARATOR
Intervention: Control group (saline)
Number of subjects: 248
Study: 32485664

Group type: EXPERIMENTAL
Intervention: 15 min/day pedaling group
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 30 min/day pedaling group
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 45 min/day pedaling group
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 60 min/day pedaling group
Number of subjects: 20
Study: 32329887

Group type: EXPERIMENTAL
Intervention: Standard therapy plus aromatherapy
Number of subjects: 38

Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 38
Study: 616866158

Group type: EXPERIMENTAL
Intervention: Active video gaming using a motion-controlled video console (Nintendo Wii) for a minimum of 30 minutes a day, 5 days a week, plus weekly Internet-based coaching sessions
Number of subjects: 13

Group type: COMPARATOR
Intervention: Waiting list (control group)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Active video gaming
Number of subjects: 13
Study: 34229729

Group type: EXPERIMENTAL
Intervention: Recombinant erythropoietin (EPREX) 300 units/Kg or 4000 IU subcutaneous injection three times a day for 5 days, along with Enoxaparin 1 mg/kg SQ daily.
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard of care (SOC) and placebo (distilled water) subcutaneous injection three times a day for 5 days.
Number of subjects: 20
Study: 32892989

Group type: EXPERIMENTAL
Intervention: Percutaneous Coronary Intervention (PCI)
Number of subjects: 748463

Group type: EXPERIMENTAL
Intervention: Coronary Artery Bypass Grafting (CABG)
Number of subjects: 748463

Group type: COMPARATOR
Intervention: Delayed Revascularization
Number of subjects: 748463
Study: 615056321

Group type: EXPERIMENTAL
Intervention: PP3M
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: PP1M
Number of subjects: 0
Study: 36041767

Group type: EXPERIMENTAL
Intervention: Deep needle insertion with combined manual and alternating-mode electrical stimulation on acupoints (AC group)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Superficial needle insertion without manual stimulation and electrical stimulation on non-acupoints (SAC group)
Number of subjects: 180

Group type: COMPARATOR
Intervention: No acupuncture intervention (NAC group)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: All groups (AC, SAC, NAC)
Number of subjects: 180
Study: 34393130

Group type: EXPERIMENTAL
Intervention: Expasyl
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Magic Foam Cord
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Traxodent
Number of subjects: 60

Group type: COMPARATOR
Intervention: Intergroup comparison between Magic Foam Cord and Traxodent
Number of subjects: 60
Study: 33264161

Group type: EXPERIMENTAL
Intervention: Cold riboflavin (4°C)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Control group (riboflavin at room temperature)
Number of subjects: 98
Study: 33064039

Group type: EXPERIMENTAL
Intervention: Auditory distraction group (ADG)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Visual distraction group (VDG)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 54
Study: 33429090

Group type: EXPERIMENTAL
Intervention: PTNS plus bladder training (BT)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: TTNS plus bladder training (BT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Bladder training (BT)
Number of subjects: 60
Study: 34190167

Group type: EXPERIMENTAL
Intervention: Palonosetron-midazolam combination therapy (group PM)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Palonosetron monotherapy (group P)
Number of subjects: 104
Study: 32105972

Group type: EXPERIMENTAL
Intervention: Nurse practitioners
Number of subjects: 1601
Study: 33068301

Group type: EXPERIMENTAL
Intervention: Saxagliptin 5mg/day (n = 40)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Vildagliptin 100mg/day (n = 40)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Traditional antidiabetic therapy (Control, n = 40)
Number of subjects: 120
Study: 33222852

Group type: EXPERIMENTAL
Intervention: High milk allowance and finely ground (FG) starter feed
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: High milk allowance and textured (TS) starter feed
Number of subjects: 48

Group type: COMPARATOR
Intervention: Low milk allowance and finely ground (FG) starter feed
Number of subjects: 48

Group type: COMPARATOR
Intervention: Low milk allowance and textured (TS) starter feed
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: High milk allowance (regardless of starter type)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Finely ground (FG) starter feeds (regardless of milk allowance)
Number of subjects: 48
Study: 35771833

Group type: EXPERIMENTAL
Intervention: Bayesian nonparametric discontinuity design (BNDD)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Kundalini Yoga meditation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Running for political positions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alleged historical phantom border in the Netherlands
Number of subjects: 0
Study: 34673765

Group type: EXPERIMENTAL
Intervention: Village-based ART refill by lay village health workers (VHWs) after same-day ART initiation
Number of subjects: 257

Group type: COMPARATOR
Intervention: Clinic-based ART refill after same-day ART initiation
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: Village-based ART refill by VHWs
Number of subjects: 257

Group type: COMPARATOR
Intervention: Clinic-based ART refill
Number of subjects: 257
Study: 35507135

Group type: EXPERIMENTAL
Intervention: FEC-100 (six cycles)
Number of subjects: 0

Group type: COMPARATOR
Intervention: AC (four cycles)
Number of subjects: 0
Study: 35857827

Group type: EXPERIMENTAL
Intervention: OP-101 at 4 mg/kg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: OP-101 at 4 and 8 mg/kg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Pooled OP-101 treatment arms
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: OP-101
Number of subjects: 24
Study: 34288239

Group type: EXPERIMENTAL
Intervention: First-line pembrolizumab (26 patients)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Second-line atezolizumab, nivolumab, or pembrolizumab (40 patients)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Overall population
Number of subjects: 66
Study: 33813267

Group type: EXPERIMENTAL
Intervention: Surgeon-delivered exercise prescription and activity tracker
Number of subjects: 18
Study: 34370964

Group type: EXPERIMENTAL
Intervention: Hibiscus sabdariffa tea
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control (water)
Number of subjects: 21
Study: 33460537

Group type: EXPERIMENTAL
Intervention: MiSight contact lenses (CLs) continued for 1 year (MiSight-C group)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: MiSight contact lenses (CLs) discontinued for 1 year (MiSight-D group)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Single vision spectacles continued for 1 year (SV-C group)
Number of subjects: 55
Study: 32166492

Group type: EXPERIMENTAL
Intervention: CT-derived fractional flow reserve (CT-FFR)
Number of subjects: 372
Study: 34906747

Group type: EXPERIMENTAL
Intervention: Distinct treatments in multi-arm trials sharing a control group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Statistical adjustment guidance
Number of subjects: 0
Study: 33421558

Group type: EXPERIMENTAL
Intervention: Atezolizumab (1200 mg intravenously every 3 weeks for 16 cycles)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Atezolizumab (840 mg intravenously every 3 weeks for 16 cycles)
Number of subjects: 8
Study: 32313032

Group type: EXPERIMENTAL
Intervention: MR stimulation (0.4 mg fludrocortisone)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: NMDA stimulation (250 mg D-cycloserine (DCS))
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Combined MR/NMDA stimulation (fludrocortisone + DCS)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Control condition (placebo)
Number of subjects: 116
Study: 36040464

Group type: EXPERIMENTAL
Intervention: 0.45% saline in 5% dextrose
Number of subjects: 200

Group type: COMPARATOR
Intervention: 0.9% normal saline in 5% dextrose
Number of subjects: 200
Study: 32540198

Group type: EXPERIMENTAL
Intervention: Radiologist visual score
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: BTS algorithm
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: ACCP algorithm
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Brock calculator
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: FDG uptake (in patients with FDG PET-CT scan, n = 78)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Herder probability (in patients with FDG PET-CT scan, n = 78)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Radiologist visual score (in patients with FDG PET-CT scan, n = 78)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: BTS algorithm (in patients with FDG PET-CT scan, n = 78)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Brock probability (in patients with FDG PET-CT scan, n = 78)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: ACCP algorithm (in patients with FDG PET-CT scan, n = 78)
Number of subjects: 150
Study: 34110620

Group type: EXPERIMENTAL
Intervention: SPI-62
Number of subjects: 0
Study: 32455501

Group type: EXPERIMENTAL
Intervention: Inset design
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Onlay round design
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Onlay oval design
Number of subjects: 120

Group type: COMPARATOR
Intervention: All designs
Number of subjects: 120
Study: 35712942

Group type: EXPERIMENTAL
Intervention: Acupuncture (at Baihui, Yintang, Anmian, Hegu, Shenmen, Taichong, Taixi), once every other day, 3 times a week for 4 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Oryzanol tablets, 20 mg orally, 3 times a day for 4 weeks
Number of subjects: 60
Study: 33581146

Group type: EXPERIMENTAL
Intervention: Take-home kits for self-collection of swabs
Number of subjects: 2862

Group type: COMPARATOR
Intervention: Trained research assistants obtaining swabs in the workplace
Number of subjects: 2862
Study: 34763746

Group type: EXPERIMENTAL
Intervention: Nutritional intervention (7-month duration) including group educational sessions, motivational cards, and informational materials.
Number of subjects: 3414

Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided).
Number of subjects: 3414
Study: 33221116

Group type: EXPERIMENTAL
Intervention: SMOFlipid (SO/MCT/OO/fish oil)
Number of subjects: 67

Group type: COMPARATOR
Intervention: MCT/LCT
Number of subjects: 67

Group type: COMPARATOR
Intervention: OO/SO
Number of subjects: 67
Study: 34038410

Group type: EXPERIMENTAL
Intervention: Combined training performed four times per week
Number of subjects: 98

Group type: COMPARATOR
Intervention: Combined training performed two times per week
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Combined training (both groups)
Number of subjects: 98
Study: 32070184

Group type: EXPERIMENTAL
Intervention: Training design for the development of empathic interaction skills
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Training design for the development of conflict management skills
Number of subjects: 62
Study: 616811449

Group type: EXPERIMENTAL
Intervention: Walnut-containing meal
Number of subjects: 28
Study: 35038950

Group type: EXPERIMENTAL
Intervention: Free spectacles group
Number of subjects: 1904

Group type: COMPARATOR
Intervention: Voucher spectacles group
Number of subjects: 1904
Study: 33597230

Group type: EXPERIMENTAL
Intervention: Thermal management with a thermal servo‐controlled system
Number of subjects: 450

Group type: COMPARATOR
Intervention: Thermal management without a thermal servo‐controlled system
Number of subjects: 450
Study: 34677647

Group type: EXPERIMENTAL
Intervention: OCV-501
Number of subjects: 134

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: OCV-501 (immune responders)
Number of subjects: 134
Study: 34404426

Group type: EXPERIMENTAL
Intervention: Care manager organization
Number of subjects: 376

Group type: COMPARATOR
Intervention: Care as usual (CAU)
Number of subjects: 376
Study: 32546217

Group type: EXPERIMENTAL
Intervention: Whey-protein-infused carbohydrate-loading drinks pre-operatively and early oral feeding post-operatively.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fasted overnight pre-operation and only allowed plain water, return to a normal diet when bowel sounds return post-operatively.
Number of subjects: 0
Study: 34696669

Group type: EXPERIMENTAL
Intervention: Autophagy-related signature based on six ARGs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Signature-based risk score
Number of subjects: 0
Study: 32669656

Group type: EXPERIMENTAL
Intervention: IBI301
Number of subjects: 181

Group type: COMPARATOR
Intervention: Rituximab
Number of subjects: 181
Study: 36135387

Group type: EXPERIMENTAL
Intervention: LSC plus LPP
Number of subjects: 130

Group type: COMPARATOR
Intervention: LSC alone
Number of subjects: 130
Study: 32654097

Group type: EXPERIMENTAL
Intervention: Aminoglycosides (gentamicin, amikacin, tobramycin)
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Specific pathogenic clone carrying ant(2" )-Ia
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: MexXY-OprM efflux pump
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: ant(2" )-Ia-encoded adenylyltransferase
Number of subjects: 147
Study: 32246254

Group type: EXPERIMENTAL
Intervention: Olfactory training ball (OTB)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Classical olfactory training (COT)
Number of subjects: 60
Study: 35055833

Group type: EXPERIMENTAL
Intervention: Mobile wellness program (12 weeks)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (Fitbit only)
Number of subjects: 60
Study: 34144923

Group type: EXPERIMENTAL
Intervention: Amikacin liposome inhalation suspension (ALIS) 590 mg once daily for 12 treatment cycles (96 weeks)
Number of subjects: 206
Study: 32822656

Group type: EXPERIMENTAL
Intervention: Physiology-guided complete revascularization
Number of subjects: 1400

Group type: COMPARATOR
Intervention: Culprit-only treatment
Number of subjects: 1400
Study: 35025755

Group type: EXPERIMENTAL
Intervention: Mobile Messaging for Men (M-cubed) app
Number of subjects: 1226

Group type: COMPARATOR
Intervention: Control group (waitlist)
Number of subjects: 1226
Study: 32749547

Group type: EXPERIMENTAL
Intervention: Immediate laryngoscopy with intubation and suctioning
Number of subjects: 40

Group type: COMPARATOR
Intervention: Immediate positive pressure ventilation (PPV) without intubation
Number of subjects: 40
Study: 35700161

Group type: EXPERIMENTAL
Intervention: One-stage technique
Number of subjects: 19

Group type: COMPARATOR
Intervention: Two-stage technique
Number of subjects: 19
Study: 32506539

Group type: EXPERIMENTAL
Intervention: Intact cord resuscitation
Number of subjects: 231

Group type: COMPARATOR
Intervention: Early cord clamping (CC)
Number of subjects: 231
Study: 34494370

Group type: EXPERIMENTAL
Intervention: SisterTalk intervention (cable-TV-delivered weight-control program)
Number of subjects: 331
Study: 33032485

Group type: EXPERIMENTAL
Intervention: Paclitaxel-eluting stent (DES)
Number of subjects: 173

Group type: COMPARATOR
Intervention: Bare-metal stent (BMS)
Number of subjects: 173
Study: 33568152

Group type: COMPARATOR
Intervention: Vastus medialis obliquus and vastus lateralis muscle areas measured in sections 0, 5, 10, 15, and 20 mm above the upper pole of the patella.
Number of subjects: 61

Group type: COMPARATOR
Intervention: Vastus medialis obliquus/vastus lateralis muscle area ratio at the upper pole of the patella (0 mm above the upper pole).
Number of subjects: 61

Group type: COMPARATOR
Intervention: Sections 5, 10, 15, and 20 mm above the upper pole of the patella.
Number of subjects: 61
Study: 32573910

Group type: EXPERIMENTAL
Intervention: N(t)RTI-based regimen
Number of subjects: 123

Group type: COMPARATOR
Intervention: Raltegravir arm
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: N(t)RTI randomization
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: P1NP increase
Number of subjects: 123
Study: 35708422

Group type: EXPERIMENTAL
Intervention: Individual counseling program based on the transtheoretical model (TM)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 67
Study: 34167672

Group type: EXPERIMENTAL
Intervention: Crushed prasugrel 60-mg loading dose
Number of subjects: 441

Group type: COMPARATOR
Intervention: Integral prasugrel 60-mg loading dose
Number of subjects: 441

Group type: EXPERIMENTAL
Intervention: Crushed prasugrel
Number of subjects: 441

Group type: EXPERIMENTAL
Intervention: Platelet reactivity <150 P2Y12 reactivity units at the beginning of coronary angiography
Number of subjects: 441
Study: 32701118

Group type: EXPERIMENTAL
Intervention: Vaginal Testosterone Cream (0.5 g daily for 2 weeks, then 0.5 g 3 times a week for 10 weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Estradiol Vaginal Ring
Number of subjects: 0
Study: 36057952

Group type: EXPERIMENTAL
Intervention: Generic safinamide tablet (test), 100 mg
Number of subjects: 56

Group type: COMPARATOR
Intervention: Brand-name safinamide tablet (reference), 100 mg
Number of subjects: 56
Study: 34459033

Group type: EXPERIMENTAL
Intervention: Melatonin (18 mg in 1 ml of corn oil, injected SC)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control (1 ml corn oil only)
Number of subjects: 12
Study: 32340524

Group type: EXPERIMENTAL
Intervention: Self-efficacy (perception that people can protect themselves from having a stroke)
Number of subjects: 552
Study: 616186217

Group type: EXPERIMENTAL
Intervention: Fibrin glue
Number of subjects: 56

Group type: COMPARATOR
Intervention: 10-0 Vicryl sutures
Number of subjects: 56
Study: 36235788

Group type: EXPERIMENTAL
Intervention: DHA/EPA group (n = 33) - received six 480 mg capsules containing 576 mg DHA and 284 mg EPA per day for 12 weeks
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo group (n = 33) - received corn oil for 12 weeks
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: DHA/EPA group (n = 33)
Number of subjects: 66
Study: 33888136

Group type: EXPERIMENTAL
Intervention: 10 mg Lutein and 2 mg Zeaxanthin in safflower oil (Carotenoid group)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Safflower oil with no added carotenoids (Control group)
Number of subjects: 0
Study: 33402937

Group type: EXPERIMENTAL
Intervention: Supine 30° HOBE
Number of subjects: 114

Group type: COMPARATOR
Intervention: Supine 0° HOBE
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Supine 45° HOBE
Number of subjects: 114
Study: 34510208

Group type: EXPERIMENTAL
Intervention: Human milk miRNAs (specifically miR-3126 and miR-3184)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Transfection of Caco-2 human intestinal cells with HM miRNAs
Number of subjects: 44
Study: 34339476

Group type: EXPERIMENTAL
Intervention: Uveitis group
Number of subjects: 195125

Group type: COMPARATOR
Intervention: Non-uveitis group
Number of subjects: 195125
Study: 32493780

Group type: EXPERIMENTAL
Intervention: Xpert MTB/Rif Ultra (Ultra)
Number of subjects: 398

Group type: EXPERIMENTAL
Intervention: Xpert MTB/Rif (Xpert)
Number of subjects: 398
Study: 32718265

Group type: EXPERIMENTAL
Intervention: Various periodontal plastic surgery procedures
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: No graft surgical approach
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Soft tissue thickness (STT)
Number of subjects: 42
Study: 33228533

Group type: EXPERIMENTAL
Intervention: Nitrogen starvation conditions
Number of subjects: 0
Study: 36190391

Group type: EXPERIMENTAL
Intervention: Abaloparatide 80 μg daily subcutaneous injections
Number of subjects: 228

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 228
Study: 34268617

Group type: EXPERIMENTAL
Intervention: Electroconvulsive therapy (ECT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Baseline/pre-ECT
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Telomerase activity
Number of subjects: 20
Study: 32175752

Group type: EXPERIMENTAL
Intervention: OnTrack + Brief Motivational Intervention (BMI)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 60
Study: 34667010

Group type: EXPERIMENTAL
Intervention: Intervention practices (n=4) with multifaceted implementation intervention including practice reimbursement, audit of attendance, electronic prompts, patient reminders, and information leaflet.
Number of subjects: 158

Group type: COMPARATOR
Intervention: Control practices (n=4) receiving usual care (wait-list control).
Number of subjects: 158
Study: 32371654

Group type: EXPERIMENTAL
Intervention: Resting-state functional connectivity (rsFC) between left middle temporal gyrus, left inferior parietal lobule, and left pulvinar
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: New metrics assessing resting-state functional connectivity pattern similarity (rsFCS)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Support vector regression based on left pulvinar connectivity patterns
Number of subjects: 100